Article Versions Notes

Yılmaz C, Zengel B, Üreyen O, Adıbelli ZH, Taşlı F, Yılmaz HT, Özdemir Ö, Kocatepe Çavdar D, Mollamehmetoğlu H, Çakıroğlu U, et al. A Comprehensive Analysis of Neoadjuvant Chemotherapy in Breast Cancer: Adverse Events, Clinical Response Rates, and Surgical and Pathological Outcomes—Bozyaka Experience. Cancers. 2025; 17(2):163. https://doi.org/10.3390/cancers17020163

Yılmaz, Cengiz, Baha Zengel, Orhan Üreyen, Zehra Hilal Adıbelli, Funda Taşlı, Hasan Taylan Yılmaz, Özlem Özdemir, Demet Kocatepe Çavdar, Hülya Mollamehmetoğlu, Umut Çakıroğlu, and et al. 2025. "A Comprehensive Analysis of Neoadjuvant Chemotherapy in Breast Cancer: Adverse Events, Clinical Response Rates, and Surgical and Pathological Outcomes—Bozyaka Experience" Cancers 17, no. 2: 163. https://doi.org/10.3390/cancers17020163

Yılmaz, C., Zengel, B., Üreyen, O., Adıbelli, Z. H., Taşlı, F., Yılmaz, H. T., Özdemir, Ö., Kocatepe Çavdar, D., Mollamehmetoğlu, H., Çakıroğlu, U., İmren, Y., Yakan, S., & İlhan, E. (2025). A Comprehensive Analysis of Neoadjuvant Chemotherapy in Breast Cancer: Adverse Events, Clinical Response Rates, and Surgical and Pathological Outcomes—Bozyaka Experience. Cancers, 17(2), 163. https://doi.org/10.3390/cancers17020163